Immunogenicity and Safety of the Spikevax ® (Moderna) mRNA SARS-CoV-2 Vaccine in Patients with Primary Humoral Immunodeficiency

Conclusion: Spikevax ® seems to be safe with satisfactory immunogenicity in patients with primary humoral immunodeficiency.Int Arch Allergy Immunol

Source: International Archives of Allergy and Immunology - October 6, 2022 Category: Allergy & Immunology Source Type: research